| BID | 10.81 | ASK | 10.84 | ||
| Open | 10.81 | Previous Close | 10.81 | ||
| Pre-Market | - | After-Market | - | ||
| - - | - -% |
| Target Price | 4.42 | Analyst Rating | — — 0.00 | |
| Potential % | -59.11 | Finscreener Ranking | ★+ — - | |
| Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | ★★★★ 57.25 | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | ★+ 41.98 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
| Price Range Ratio 52W % | 47.59 | Earnings Rating | Buy | |
| Market Cap | 147.20M | Earnings Date | 20th Mar 2020 | |
| Alpha | 0.00 | Standard Deviation | 0.01 | |
| Beta | 0.02 |
Today's Price Range 10.8110.81 | 52W Range 10.0211.68 |
Summary:
Buy
| Technical Indicators: | Neutral |
| Moving Averages: | Strong Buy |
| Performance | |||
|---|---|---|---|
| 1 Week | 0.28% | ||
| 1 Month | 0.84% | ||
| 3 Months | 2.08% | ||
| 6 Months | 3.64% | ||
| 1 Year | 7.67% | ||
| 3 Years | - | ||
| 5 Years | 248.71% | ||
| 10 Years | 3.84% |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | -835.02 | |||
ROE last 12 Months | 0.38 | |||
ROA (5Y Avg) | -7.98 | |||
ROA last 12 Months | 0.36 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -0.21 | |||
Return on invested Capital Q | 0.04 | |||
Return on invested Capital Y | - | |||
Assets Turnover | 0.00 | |||
Receivables Turnover | 7.10 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -1 455.70 | ||||
| 2.95 | ||||
| 1.91 | ||||
| 110.70 | ||||
| -653.60 | ||||
| 0.03 | ||||
| 1.36 | ||||
| 1.31 | ||||
| 306.20M | ||||
| Forward PE | 410.00 | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 0.40 | ||||
| 2.20 | ||||
| 0.02 | ||||
| 0.02 | ||||
| - | ||||
| Leverage Ratio | 1.10 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 22.50 | ||||
| -0.50 | ||||
| 2.00 | ||||
| -11.90 | ||||
| -3.87 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 0.00 | ||||
| 0.00 | ||||
| 9.49 | ||||
| 1.34 |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q03 2019 | -0.01 | -0.01 | 0.00 |
| Q02 2019 | -0.10 | -0.13 | -30.00 |
| Q01 2019 | -0.12 | -0.10 | 16.67 |
| Q04 2018 | -0.03 | -0.14 | -366.67 |
| Q03 2018 | -0.07 | -0.09 | -28.57 |
| Q02 2018 | -0.10 | -0.14 | -40.00 |
| Q01 2018 | -0.11 | -0.12 | -9.09 |
| Q04 2017 | -0.08 | -0.15 | -87.50 |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| 12/2019 QR | 0.00 | -100.00 | Negative |
| 12/2019 FY | -0.21 | -16.67 | Negative |
| 3/2020 QR | -0.01 | -200.00 | Negative |
| 12/2020 FY | 0.00 | -100.00 | Negative |
| Next Report Date | - |
| Estimated EPS Next Report | - |
| Estimates Count | 2 |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 10.00K |
| Shares Outstanding | 13.62K |
| Shares Float | 13.62M |
| Trades Count | 1 |
| Dollar Volume | 108.10K |
| Avg. Volume | 25.01K |
| Avg. Weekly Volume | 15.12K |
| Avg. Monthly Volume | 16.06K |
| Avg. Quarterly Volume | 43.85K |
BioScrip Inc. (NASDAQ: BIOS) stock closed at 10.81 per share at the end of the most recent trading day (a 0% change compared to the prior day closing price) with a volume of 10.00K shares and market capitalization of 147.20M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 2043 people. BioScrip Inc. CEO is John Charles Rademacher.
The one-year performance of BioScrip Inc. stock is 7.67%, while year-to-date (YTD) performance is 5.77%. BIOS stock has a five-year performance of 248.71%. Its 52-week range is between 10.02 and 11.68, which gives BIOS stock a 52-week price range ratio of 47.59%
BioScrip Inc. currently has a PE ratio of -1 455.70, a price-to-book (PB) ratio of 2.95, a price-to-sale (PS) ratio of 1.91, a price to cashflow ratio of 110.70, a PEG ratio of -, a ROA of 0.36%, a ROC of -0.21% and a ROE of 0.38%. The company’s profit margin is -3.87%, its EBITDA margin is 2.00%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.
Of the last four earnings reports from BioScrip Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. BioScrip Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for BioScrip Inc. is — (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for BioScrip Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
BioScrip Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
BioScrip Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 10.53, ATR14 : 0.05, CCI20 : 29.19, Chaikin Money Flow : 0.25, MACD : 0.03, Money Flow Index : 74.61, ROC : 0.37, RSI : 60.65, STOCH (14,3) : 62.50, STOCH RSI : 0.22, UO : 47.28, Williams %R : -37.50), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of BioScrip Inc. in the last 12-months were:
BioScrip Inc.
Option Care Health Inc formerly known as BioScrip Inc is one of the provider of home infusion services and home care management solutions in the United States. The firm's home infusion services primarily involve the intravenous administration of medications treating a wide range of acute and chronic conditions, such as infections, nutritional deficiencies, various immunologic and neurologic disorders, cancer, pain and palliative care. It provides a wide array of home infusion products and services to meet the diverse needs of physicians, patients, and payors.
CEO: John Charles Rademacher
Telephone: +1 312 940-2443
Address: 3000 Lakeside Dr., Bannockburn 60015, IL, USA
Number of employees: 2 043
